Who owns APELLIS PHARMACEUTICALS INC?
- CUSIP Number: 03753uab2
Tip: Access positions for across all investors
Analyze quarterly positions in Apellis Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Apellis Pharmaceuticals stock
Who bought or sold APELLIS PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| DeepCurrents Investment Group | 44M | $46M | 0% | Sep 2025 |
|
| Linden Advisors | 28M | $29M | 0% | Sep 2025 |
|
| Tenor Capital Management | 12M | $12M | 0% | Sep 2025 |
|
| D. E. Shaw & Co | 5.0M | $5.2M | 0% | Sep 2025 |
|
| Wolverine Asset Management | 3.1M | $3.2M | 5% | Sep 2025 |
|
| Wellington Management Company | 1.1M | $1.2M | -12% | Sep 2025 |
|
| Kornitzer Capital Management | 300k | $310k | 0% | Sep 2025 |
|
Who sold out of Apellis Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jpmorgan Chase & Co | Mar 2025 | 300k | $334k |